A pooled analysis of seven large pen feedlot studies: influence of Megasphaera elsdenii NCIMB 41125 on late-term mortality and growth performance of feedlot steers and heifers following terminal processing
Abstract
Abstract Large pen feedlot studies (n = 7) with heifers and steers (n = 17,571) were conducted in North America to determine the effects of orally administered Megasphaera elsdenii NCIMB 41125 (Lactipro; Axiota Animal Health, Fort Collins, CO, USA) on late feeding period mortality and growth performance. Study designs were randomized complete blocks, and treatments included no administration of Megasphaera elsdenii NCIMB 41125 (CON) and administration of a commercial dose of Megasphaera elsdenii NCIMB 41125 (LP). Treatments were administered 51 to 147 d on feed to coincide with terminal implant administration and/or sorting into marketing cohorts, on subsequent mortality and growth performance. Data were analyzed with linear mixed models to account for the hierarchical design structure and fitted for mortality and performance outcomes. Mortality incidence was reduced (P = 0.005) when dosing Megasphaera elsdenii NCIMB 41125 [0.011 vs. 0.007 (per 100 head days) ± 0.002 for CON versus LP cattle, respectively]. Thus, the death rate during the risk period was 1.57 times greater in cattle not administered LP. No treatment × sex interaction (P ≥ 0.53) was observed for any growth performance measures. A significant effect of sex (P < 0.01) was observed for dry matter intake (DMI), average daily gain (ADG), and gain:feed (G:F), with steers exhibiting increased performance across all outcomes. No difference (P ≥ 0.18) between treatments was noted for DMI, ADG, or G:F. Orally…
How strong is the evidence?
Evidence Hub reads this as a secondary / pooled analysis. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 17,571 participants or records.
Read the paper
Related studies
- Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
- A meta‐analysis of anal cancer incidence by risk group: Toward a unified anal cancer risk scale
- Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
- Exercise interventions in Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials
- Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis
- Glucocorticoid Resistance: Is It a Requisite for Increased Cytokine Production in Depression? A Systematic Review and Meta-Analysis
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.